HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity
Bethlehem, PA, USA, April 12, 2021 – ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced it will design, manufacture, and install multiple 4,000L fermenter trains for HEC…
ABEC CSR® Single-Use Fermenters to Support Catalent Cell & Gene Therapy Manufacturing Expansion
Bethlehem, PA, USA, April 6, 2021 – ABEC, a leading global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced that it has supplied two 50L CSR single-use fermenters…
mAbxience Expanding Biosimilar and CDMO Manufacturing Capacity with ABEC 4,000 Liter Single-Use Bioreactor
Bethlehem, PA, USA, March 23, 2021, ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced mAbxience will equip their state-of-the-art cGMP facility in León, Spain with…
Qilu Pharmaceutical and ABEC Continue Large-Scale Bioreactor Partnership
Bethlehem, PA, USA, November 12, 2020 – ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced Qilu Pharmaceutical Co. has again selected ABEC to rapidly expand…